ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study

Sun, Zepang; Wang, Wei; Huang, Weicai; Zhang, Taojun; Chen, Chuanli; Yuan, Qingyu; Chen, Yan; Zhou, Kangneng; Han, Zhen; Feng, Hao; Chen, Hao; Liang, Xiaokun; Hu, Yanfeng; Yu, Jiang; Liu, Hao; Yu, Lequan; Xu, Yikai*; Li, Guoxin*; Jiang, Yuming*北京科技大学; 南方医科大学; 中山大学; 中国科学院研究生院; 中国科学院; 1
International Journal of Surgery2023-7DOI: 10.1097/JS9.0000000000000328
5阅读
引用收藏
分享

摘要

Background: Peritoneal recurrence (PR) is the predominant pattern of relapse after curative-intent surgery in gastric cancer (GC) and indicates a dismal prognosis. Accurate prediction of PR is crucial for patient management and treatment. The authors aimed to develop a noninvasive imaging biomarker from computed tomography (CT) for PR evaluation, and investigate its associations with prognosis and chemotherapy benefit. Methods: In this multicenter study including five independent cohorts of 2005 GC patients, the authors extracted 584 quantitative features from the intratumoral and peritumoral regions on contrast-enhanced CT images. The artificial intelligence algorithms were used to select significant PR-related features, and then integrated into a radiomic imaging signature. And improvements of diagnostic accuracy for PR by clinicians with the signature assistance were quantified. Using Shapley values, the authors determined the most relevant features and provided explanations to prediction. The authors further evaluated its predictive performance in prognosis and chemotherapy response. Results: The developed radiomics signature had a consistently high accuracy in predicting PR in the training cohort (area under the curve: 0.732) and internal and Sun Yat-sen University Cancer Center validation cohorts (0.721 and 0.728). The radiomics signature was the most important feature in Shapley interpretation. The diagnostic accuracy of PR with the radiomics signature assistance was improved by 10.13-18.86% for clinicians (P< 0.001). Furthermore, it was also applicable in the survival prediction. In multivariable analysis, the radiomics signature remained an independent predictor for PR and prognosis (P< 0.001 for all). Importantly, patients with predicting high risk of PR from radiomics signature could gain survival benefit from adjuvant chemotherapy. By contrast, chemotherapy had no impact on survival for patients with a predicted low risk of PR. Conclusion: The noninvasive and explainable model developed from preoperative CT images could accurately predict PR and chemotherapy benefit in patients with GC, which will allow the optimization of individual decision-making.

学科与关键词

关键词
artificial intelligencechemotherapy benefitgastric cancernoninvasive evaluationperitoneal recurrence
相关
加载中…
  • Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study
    Jiang, Yuming; Zhang, Zhicheng; Yuan, Qingyu; Wang, Wei; Wang, Hongyu; Li, Tuanjie; Huang, Weicai; Xie, Jingjing; Chen, Chuanli; Sun, Zepang; Yu, Jiang; Xu, Yikai; Poultsides, George A.; Xing, Lei; Zhou, Zhiwei*; Li, Guoxin*; Li, Ruijiang*Lancet Digital Health, 2022, 4(5): E340-E350.被引 32
  • Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer
    Jiang, Yuming; Jin, Cheng; Yu, Heng; Wu, Jia; Chen, Chuanli; Yuan, Qingyu; Huang, Weicai; Hu, Yanfeng; Xu, Yikai; Zhou, Zhiwei*; Fisher, George A., Jr.; Li, Guoxin*; Li, Ruijiang*Annals of Surgery, 2021, 274(6): E1153-E1161.被引 108
  • Predicting peritoneal recurrence in gastric cancer with serosal invasion using a pathomics nomogram
    Chen, Dexin; Lai, Jianbo; Cheng, Jiaxin; Fu, Meiting; Lin, Liyan; Chen, Feng; Huang, Rong; Chen, Jun; Lu, Jianping; Chen, Yuning; Huang, Guangyao; Yan, Miaojia; Ma, Xiaodan; Li, Guoxin*; Chen, Gang*; Yan, Jun*iScience, 2023, 26(3): 106246.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Surgery
发表日期
2023-07
卷期
第 109 卷, 第 7 期
页码
2010-2024
DOI
10.1097/JS9.0000000000000328
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82102156, 81872013]; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer [2020B121201004]; Guangdong Provincial Major Talents Project [2019JC05Y361]; Natural Science Foundation of Guangdong Province [2019A1515011445]; Key-Area Research and Development Program of Guangdong Province [2021B0101420005]

作者

  • S

    Sun, Zepang (第一作者)

    1 · southern med univ

  • W

    Wang, Wei

    sun yat sen univ

查看全部 19 位作者收起作者
  • H

    Huang, Weicai

    1 · southern med univ

  • Z

    Zhang, Taojun

    1 · southern med univ

  • C

    Chen, Chuanli

    southern med univ

  • Y

    Yuan, Qingyu

    southern med univ

  • C

    Chen, Yan

  • Z

    Zhou, Kangneng

    univ sci & technol beijing

  • H

    Han, Zhen

    1 · southern med univ

  • F

    Feng, Hao

    1 · southern med univ

  • C

    Chen, Hao

    1 · southern med univ

  • L

    Liang, Xiaokun

    chinese acad sci · univ chinese acad sci

  • H

    Hu, Yanfeng

    1 · southern med univ

  • Y

    Yu, Jiang

  • L

    Liu, Hao

    1 · southern med univ

  • Y

    Yu, Lequan

    univ hong kong

  • X

    Xu, Yikai (通讯)

    southern med univ

  • L

    Li, Guoxin (通讯)

    1 · southern med univ

  • J

    Jiang, Yuming (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417